Kiniksa posts first-quarter loss

1d ago, source: The Royal Gazette

Kiniksa Pharmaceuticals Ltd, the commercial-stage biopharmaceutical company that proposes to change its place of ...

Can Growing Adoption Of Arcalyst Drive KNSA Stock Up?

1d ago, source:

Kiniksa Pharmaceuticals Ltd.'s (KNSA) flagship product Arcalyst has garnered widespread acclaim and acceptance since its launch in ...

KNSA Kiniksa Pharmaceuticals, Ltd.

2d ago, source: Seeking Alpha

Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating ...

Kiniksa Pharmaceuticals

21d ago, source: Forbes

Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating ...

Buy Rating Affirmed for Kiniksa Pharmaceuticals Amid Strong Q1 Performance and Promising Drug Prospects

2d ago, source:

In a report released yesterday, Geoff Meacham from Bank of America Securities reiterated a Buy rating on Kiniksa Pharmaceuticals (KNSA – ...

Kiniksa shareholders’ meeting to be held on June 5

4d ago, source: The Royal Gazette

Shareholders of a Bermuda-domiciled biopharmaceutical company that is proposing to change its place of incorporation to the ...

Kiniksa Pharmaceuticals Ltd Class A

10d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Marquette National Corporation Reports First Quarter 2024 Results

1h ago, source:

Marquette National Corporation is a diversified financial holding company and the parent of Marquette Bank, a full-service, community bank that serves the financial needs of communities in Chicagoland ...